TY  - JOUR
AU  - Munteanu, M
AU  - Tiniakos, D
AU  - Anstee, Q
AU  - Charlotte, F
AU  - Marchesini, G
AU  - Bugianesi, E
AU  - Trauner, M
AU  - Romero Gomez, M
AU  - Oliveira, C
AU  - Day, C
AU  - Dufour, J-F
AU  - Bellentani, S
AU  - Ngo, Y
AU  - Traussnig, S
AU  - Perazzo, H
AU  - Deckmyn, O
AU  - Bedossa, P
AU  - Ratziu, V
AU  - Poynard, T
AU  - FLIP Consortium and the FibroFrance Group
PY  - 2016
DO  - 10.1111/apt.13770
UR  - http://hdl.handle.net/10668/10381
T2  - Alimentary pharmacology & therapeutics
AB  - Blood tests of liver injury are less well validated in non-alcoholic fatty liver disease (NAFLD) than in patients with chronic viral hepatitis. To improve the validation of three blood tests used in NAFLD patients, FibroTest for fibrosis staging,...
LA  - en
KW  - Biopsy
KW  - Fatty Liver
KW  - Female
KW  - Hematologic Tests
KW  - Humans
KW  - Inflammation
KW  - Liver Cirrhosis
KW  - Male
KW  - Middle Aged
KW  - Non-alcoholic Fatty Liver Disease
KW  - Prospective Studies
TI  - Diagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological reference.
TY  - research article
VL  - 44
ER  -